Group 2 innate lymphoid cells and asthma
Open Access
- 1 July 2015
- journal article
- review article
- Published by Elsevier BV in Allergology International
- Vol. 64 (3), 227-234
- https://doi.org/10.1016/j.alit.2015.03.004
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (25461504)
- Ministry of Health, Labour, and Welfare
This publication has 82 references indexed in Scilit:
- The Transcription Factor GATA-3 Controls Cell Fate and Maintenance of Type 2 Innate Lymphoid CellsImmunity, 2012
- Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathologyNature Medicine, 2012
- Transcription factor RORα is critical for nuocyte developmentNature Immunology, 2012
- Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunityNature Immunology, 2011
- Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunityJournal of Allergy and Clinical Immunology, 2011
- An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammationNature Immunology, 2011
- Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populationsNature Genetics, 2011
- Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunityNature Immunology, 2011
- A Large-Scale, Consortium-Based Genomewide Association Study of AsthmaNew England Journal of Medicine, 2010
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunityNature, 2010